Nektar Therapeutics | NKTR - Operating Profit


Nektar Therapeutics reported $-19.09M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
ALKERMES USD -10.95M 100.03M Dec/2025
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 3.96B 464M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 235.91M 20.45M Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Incyte USD 383.88M 47.43M Dec/2025
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -17.84M 13.44M Dec/2025
MacroGenics USD -12.1M 30.74M Dec/2025
Merck USD 6.24B 318M Dec/2025
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Neurocrine Biosciences USD 227.9M 11.4M Dec/2025
Novartis USD 4.06B 437M Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Takeda JPY 168.82B 479.89B Dec/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
Xencor USD -53.63M 6.11M Dec/2025